Breaking News
Get 40% Off 0
🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For Free Copy Portfolio
Close

Kaken Pharmaceutical Co Ltd (4521)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3,575.0 -91.0    -2.48%
02:00:29 - Closed. Currency in JPY ( Disclaimer )
Type:  Equity
Market:  Japan
ISIN:  JP3207000005 
  • Volume: 401,200
  • Bid/Ask: 3,572.0 / 3,577.0
  • Day's Range: 3,534.0 - 3,674.0
Kaken Pharmaceutical Co Ltd 3,575.0 -91.0 -2.48%

4521 Balance Sheet

 
Featured here, the Balance Sheet for Kaken Pharmaceutical Co Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 106974 110335 112745 109318
Cash and Short Term Investments 65324 66152 70060 71534
Cash - - - -
Cash & Equivalents 50625 51453 55361 56835
Short Term Investments 14699 14699 14699 14699
Total Receivables, Net 23744 24554 23998 20163
Accounts Receivables - Trade, Net 23744 24554 23998 20163
Total Inventory 17167 18876 17857 16833
Prepaid Expenses - - - -
Other Current Assets, Total 739 753 830 788
Total Assets 171623 168337 171651 167151
Property/Plant/Equipment, Total - Net 25354 24547 24979 25055
Property/Plant/Equipment, Total - Gross 73937 - - -
Accumulated Depreciation, Total -48583 - - -
Goodwill, Net - - - -
Intangibles, Net 7462 7483 7538 6766
Long Term Investments 20532 25970 26387 26010
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 8711 2 2 2
Other Assets, Total 11451 9774 9388 12157
Total Current Liabilities 19024 19550 22160 20465
Accounts Payable 11122 8283 8253 7198
Payable/Accrued - - - -
Accrued Expenses 1639 461 877 460
Notes Payable/Short Term Debt 3850 3850 3850 3850
Current Port. of LT Debt/Capital Leases - - - -
Other Current liabilities, Total 2413 6956 9180 8957
Total Liabilities 27868 28201 30923 29319
Total Long Term Debt - - - -
Long Term Debt - - - -
Capital Lease Obligations - - - -
Deferred Income Tax 1947 1771 1771 1771
Minority Interest - - - 578
Other Liabilities, Total 3047 -820 -708 2655
Total Equity 143755 140136 140728 137832
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 23853 23853 23853 23853
Additional Paid-In Capital 11462 11462 11462 11406
Retained Earnings (Accumulated Deficit) 128506 127155 127390 125832
Treasury Stock - Common -28613 -28613 -28612 -30027
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 8547 6279 6635 6768
Total Liabilities & Shareholders' Equity 171623 168337 171651 167151
Total Common Shares Outstanding 37.87 37.87 37.87 37.47
Total Preferred Shares Outstanding - - - -
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

4521 Comments

Write your thoughts about Kaken Pharmaceutical Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email